{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:41:57Z","timestamp":1792190517641,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pain management is a critical component of comprehensive postsurgical care, as it influences patient safety and outcomes, and inadequate control has been associated with the development of chronic pain syndromes. Despite recent improvements, the management of postoperative pain following total knee arthroplasty (TKA) remains a challenge. The use of opioid-sparing, multimodal analgesic regimens has broad support, but there is a paucity of high-quality evidence regarding optimal postoperative protocols and novel approaches are needed. Dextromethorphan stands out among both well-studied and emerging pharmacological adjuncts for postoperative pain due its robust safety profile and unique pharmacology. The purpose of this study is to evaluate the efficacy of multi-dose dextromethorphan for postoperative pain control following TKA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a single-center, multi-dose, randomized, double-blinded, placebo-controlled trial. A total of\u2009160 participants will be randomized 1:1 to receive either 60\u00a0mg oral dextromethorphan hydrobromide preoperatively, as well as 30\u00a0mg 8\u00a0h and 16\u00a0h postoperatively, or matching placebo. Outcome data will be obtained at baseline, during the first 48\u00a0h, and the first two follow-up visits. The primary outcome measure will be total opioid consumption at 24\u00a0h postoperatively. Secondary outcomes related to pain, function, and quality of life will be evaluated using standard pain scales, the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR) questionnaire, the Patient-Reported Outcomes Measurement Information System (PROMIS-29) questionnaire, and clinical anchors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study has a number of strengths including adequate power, a randomized controlled design, and an evidence-based dosing schedule. As such, it will provide the most robust evidence to date on dextromethorphan utilization for postoperative pain control following TKA. Limitations include not obtaining serum samples for pharmacokinetic analysis and the single-center study design.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>This trial has been registered on the National Institute of Health\u2019s<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\">ClinicalTrials.gov<\/jats:ext-link>(NCT number: NCT05278494). Registered on March 14, 2022.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13063-023-07240-0","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T22:02:44Z","timestamp":1680127364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A double-blinded, placebo-controlled, randomized study to evaluate the efficacy of perioperative dextromethorphan compared to placebo for the treatment of postoperative pain: a study protocol"],"prefix":"10.1186","volume":"24","author":[{"given":"Ian A.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit S.","family":"Piple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Yuk","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"Longjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay R.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gligor V.","family":"Gucev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina E.","family":"Ratto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-1702","authenticated-orcid":false,"given":"Nathanael D.","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"7240_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5812\/aapm.1810","volume":"1","author":"F Imani","year":"2011","unstructured":"Imani F. Postoperative pain management. Anesthesiol Pain Med. 2011;1:6\u20137.","journal-title":"Anesthesiol Pain Med"},{"key":"7240_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5812\/kowsar.22287523.3443","volume":"1","author":"S Shoar","year":"2012","unstructured":"Shoar S, Esmaeili S, Safari S. Pain management after surgery: a brief review. Anesthesiol Pain Med. 2012;1:184\u20136.","journal-title":"Anesthesiol Pain Med"},{"key":"7240_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/ALN.0b013e31828866b3","volume":"118","author":"HJ Gerbershagen","year":"2013","unstructured":"Gerbershagen HJ, Aduckathil S, van Wijck AJM, Peelen LM, Kalkman CJ, Meissner W. Pain intensity on the first day after surgery. Anesthesiology. 2013;118:934\u201344.","journal-title":"Anesthesiology"},{"key":"7240_CR4","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1056\/NEJMe0801783","volume":"358","author":"C Berde","year":"2008","unstructured":"Berde C, Nurko S. Opioid side effects \u2014 mechanism-based therapy. New Engl J Med. 2008;358:2400\u20132.","journal-title":"New Engl J Med"},{"key":"7240_CR5","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2106\/JBJS.21.00045","volume":"103","author":"BC Chung","year":"2021","unstructured":"Chung BC, Bouz GJ, Mayfield CK, Nakata H, Christ AB, Oakes DA, et al. Dose-dependent early postoperative opioid use is associated with periprosthetic joint infection and other complications in primary TJA. J Bone Joint Surg. 2021;103:1531\u201342.","journal-title":"J Bone Joint Surg"},{"key":"7240_CR6","doi-asserted-by":"publisher","first-page":"e67-1-2","DOI":"10.2106\/JBJS.21.00523","volume":"103","author":"WG Hamilton","year":"2021","unstructured":"Hamilton WG. The dangers of opioids: more than just addiction: commentary on an article by Brian C. Chung, BS, et al.: \u201cDose-dependent early postoperative opioid use is associated with periprosthetic joint infection and other complications in primary TJA.\u201d J Bone Joint Surg. 2021;103:e67-1\u20132.","journal-title":"J Bone Joint Surg"},{"key":"7240_CR7","doi-asserted-by":"publisher","first-page":"e15425","DOI":"10.1097\/MD.0000000000015425","volume":"98","author":"N Stoicea","year":"2019","unstructured":"Stoicea N, Costa A, Periel L, Uribe A, Weaver T, Bergese SD. Current perspectives on the opioid crisis in the US healthcare system: a comprehensive literature review. Medicine. 2019;98:e15425.","journal-title":"Medicine"},{"key":"7240_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12630-015-0520-y","volume":"63","author":"A Alam","year":"2016","unstructured":"Alam A, Juurlink DN. The prescription opioid epidemic: an overview for anesthesiologists. Can J Anesthesia J Can D\u2019anesth\u00e9sie. 2016;63:61\u20138.","journal-title":"Can J Anesthesia J Can D\u2019anesth\u00e9sie"},{"key":"7240_CR9","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.5435\/JAAOS-D-21-00360","volume":"30","author":"A Premkumar","year":"2021","unstructured":"Premkumar A, Zhong H, Krell E, Liu J, Memtsoudis S, Poeran J, et al. The opioid epidemic in the United States: where do patients requiring elective arthroplasty stand? J Am Acad Orthop Sur. 2021;30:e213\u201322.","journal-title":"J Am Acad Orthop Sur"},{"key":"7240_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3928\/01477447-20130122-51","volume":"36","author":"J Parvizi","year":"2013","unstructured":"Parvizi J, Bloomfield MR. Multimodal pain management in orthopedics: implications for joint arthroplasty surgery. Orthopedics. 2013;36:7\u201314.","journal-title":"Orthopedics"},{"key":"7240_CR11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jocn.2015.01.003","volume":"22","author":"CJ Devin","year":"2015","unstructured":"Devin CJ, McGirt MJ. Best evidence in multimodal pain management in spine surgery and means of assessing postoperative pain and functional outcomes. J Clin Neurosci. 2015;22:930\u20138.","journal-title":"J Clin Neurosci"},{"key":"7240_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/ACO.0b013e32833fad0a","volume":"23","author":"OL Elvir-Lazo","year":"2010","unstructured":"Elvir-Lazo OL, White PF. The role of multimodal analgesia in pain management after ambulatory surgery. Curr Opin Anesthesio. 2010;23:697.","journal-title":"Curr Opin Anesthesio"},{"key":"7240_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.pharmthera.2016.04.010","volume":"164","author":"CP Taylor","year":"2016","unstructured":"Taylor CP, Traynelis SF, Siffert J, Pope LE, Matsumoto RR. Pharmacology of dextromethorphan: relevance to dextromethorphan\/quinidine (Nuedexta\u00ae) clinical use. Pharmacol Therapeut. 2016;164:170\u201382.","journal-title":"Pharmacol Therapeut"},{"key":"7240_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2165\/00002018-199207030-00004","volume":"7","author":"JL Bem","year":"1992","unstructured":"Bem JL, Peck R. Dextromethorphan. Drug Saf. 1992;7:190\u20139.","journal-title":"Drug Saf"},{"key":"7240_CR15","unstructured":"Oh S, Agrawal S, Sabir S, Taylor A. Dextromethorphan. StatPearls;\u00a02021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538216\/."},{"key":"7240_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.01.016","volume":"159","author":"L Nguyen","year":"2016","unstructured":"Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR. Dextromethorphan: an update on its utility for neurological and neuropsychiatric disorders. Pharmacol Therapeut. 2016;159:1\u201322.","journal-title":"Pharmacol Therapeut"},{"key":"7240_CR17","first-page":"9","volume":"243","author":"LM Aanonsen","year":"1987","unstructured":"Aanonsen LM, Wilcox GL. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther. 1987;243:9\u201319.","journal-title":"J Pharmacol Exp Ther"},{"key":"7240_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1527-3458.2007.00006.x","volume":"13","author":"A Siu","year":"2007","unstructured":"Siu A, Drachtman R. Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain. Cns Drug Rev. 2007;13:96\u2013106.","journal-title":"Cns Drug Rev"},{"key":"7240_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/cne.902770210","volume":"277","author":"G Battaglia","year":"1988","unstructured":"Battaglia G, Rustioni A. Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J Comp Neurol. 1988;277:302\u201312.","journal-title":"J Comp Neurol"},{"key":"7240_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1213\/00000539-199377020-00026","volume":"77","author":"CJ Woolf","year":"1993","unstructured":"Woolf CJ, Chong M-S. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesthesia Analgesia. 1993;77:362.","journal-title":"Anesthesia Analgesia"},{"key":"7240_CR21","doi-asserted-by":"crossref","first-page":"e114318","DOI":"10.5812\/aapm.114318","volume":"11","author":"A Fahmi","year":"2021","unstructured":"Fahmi A, Aji YK, Aprianto DR, Wido A, Asadullah A, Roufi N, et al. The effect of intrathecal injection of dextromethorphan on the experimental neuropathic pain model. Anesthesiol Pain Medicine. 2021;11:e114318.","journal-title":"Anesthesiol Pain Medicine"},{"key":"7240_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2004.11.015","volume":"113","author":"TH Duedahl","year":"2005","unstructured":"Duedahl TH, Dirks J, Petersen KB, Romsing J, Larsen N-E, Dahl JB. Intravenous dextromethorphan to human volunteers: relationship between pharmacokinetics and anti-hyperalgesic effect. Pain. 2005;113:360\u20138.","journal-title":"Pain"},{"key":"7240_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/ALN.0000000000000950","volume":"124","author":"MR King","year":"2016","unstructured":"King MR, Ladha KS, Gelineau AM, Anderson TA. Perioperative dextromethorphan as an adjunct for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology. 2016;124:696\u2013705.","journal-title":"Anesthesiology"},{"key":"7240_CR24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1046\/j.1365-2044.2001.02088.x","volume":"56","author":"AA Weinbroum","year":"2001","unstructured":"Weinbroum AA, Lalayev G, Yashar T, Ben-Abraham R, Niv D, Flaishon R. Combined pre-incisional oral dextromethorphan and epidural lidocaine for postoperative pain reduction and morphine sparing: a randomised double-blind study on day-surgery patients. Anaesthesia. 2001;56:616\u201322.","journal-title":"Anaesthesia"},{"key":"7240_CR25","first-page":"1547","volume":"94","author":"AA Weinbroum","year":"2002","unstructured":"Weinbroum AA. Dextromethorphan reduces immediate and late postoperative analgesic requirements and improves patients\u2019 subjective scorings after epidural lidocaine and general anesthesia. Anesthesia Analgesia. 2002;94:1547.","journal-title":"Anesthesia Analgesia"},{"key":"7240_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1213\/00000539-200102000-00032","volume":"92","author":"A Wadhwa","year":"2001","unstructured":"Wadhwa A, Clarke D, Goodchild CS, Young D. Large-dose oral dextromethorphan as an adjunct to patient-controlled analgesia with morphine after knee surgery. Anesthesia Analgesia. 2001;92:448.","journal-title":"Anesthesia Analgesia"},{"key":"7240_CR27","first-page":"e11187","volume":"4","author":"SR Entezary","year":"2013","unstructured":"Entezary SR, Farshadpour S, Alebouyeh MR, Imani F, Meybodi MKE, Yaribeygi H. Effects of preoperative use of oral dextromethorphan on postoperative need for analgesics in patients with knee arthroscopy. Anesthesiol Pain Med. 2013;4:e11187.","journal-title":"Anesthesiol Pain Med"},{"key":"7240_CR28","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/j.1541-0420.2008.01138_10.x","volume":"64","author":"DH Glueck","year":"2008","unstructured":"Glueck DH. Sample size calculations in clinical research 2nd edition by CHOW, S-C, SHAO J, and WANG, H. Biometrics. 2008;64:1307\u20138.","journal-title":"Biometrics."},{"key":"7240_CR29","unstructured":"MPH SBHM, MD SRC, MPH WSBM, MPH DGGM, MPH TBNM. Designing clinical research: an epidemiologic approach. 4th ed. Lippincott Williams & Wilkins; 2013. https:\/\/tilda.tcd.ie\/epidemiology-biostatistics-course\/coursematerial\/assets\/Class2\/Designingclinicalresearch_4th-edition.pdf."},{"key":"7240_CR30","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s11999-016-4719-1","volume":"474","author":"S Lyman","year":"2016","unstructured":"Lyman S, Lee Y-Y, Franklin PD, Li W, Cross MB, Padgett DE. Validation of the KOOS, JR: a short-form knee arthroplasty outcomes survey. Clin Orthop Relat Res. 2016;474:1461\u201371.","journal-title":"Clin Orthop Relat Res"},{"key":"7240_CR31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.joca.2015.03.011","volume":"23","author":"E Losina","year":"2015","unstructured":"Losina E, Ranstam J, Collins JE, Schnitzer TJ, Katz JN. OARSI clinical trials recommendations: key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis. Osteoarthr Cartilage. 2015;23:677\u201385.","journal-title":"Osteoarthr Cartilage"},{"key":"7240_CR32","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/acr.23183","volume":"69","author":"P Katz","year":"2017","unstructured":"Katz P, Pedro S, Michaud K. Performance of the patient-reported outcomes measurement information system 29-item profile in rheumatoid arthritis, osteoarthritis, fibromyalgia, and systemic lupus erythematosus. Arthrit Care Res. 2017;69:1312\u201321.","journal-title":"Arthrit Care Res"},{"key":"7240_CR33","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jor.23739","volume":"36","author":"M Hung","year":"2018","unstructured":"Hung M, Saltzman CL, Greene T, Voss MW, Bounsanga J, Gu Y, et al. Evaluating instrument responsiveness in joint function: the HOOS JR, the KOOS JR, and the PROMIS PF CAT. J Orthop Res. 2018;36:1178\u201384.","journal-title":"J Orthop Res"},{"key":"7240_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12891-018-2300-7","volume":"19","author":"IA Jones","year":"2018","unstructured":"Jones IA, Wilson M, Togashi R, Han B, Mircheff AK, Thomas Vangsness C Jr. A randomized, controlled study to evaluate the efficacy of intra-articular, autologous adipose tissue injections for the treatment of mild-to-moderate knee osteoarthritis compared to hyaluronic acid: a study protocol. BMC Musculoskelet Di. 2018;19:383.","journal-title":"BMC Musculoskelet Di"},{"key":"7240_CR35","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.jse.2019.12.033","volume":"29","author":"IA Jones","year":"2020","unstructured":"Jones IA, Togashi R, Heckmann N, Vangsness CT. Minimal clinically important difference (MCID) for patient-reported shoulder outcomes. J Shoulder Elb Surg. 2020;29:1484\u201392.","journal-title":"J Shoulder Elb Surg"},{"key":"7240_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","volume":"10","author":"R Jaeschke","year":"1989","unstructured":"Jaeschke R, Singer J, Guyatt GH. Measurement of health status ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407\u201315.","journal-title":"Control Clin Trials"},{"key":"7240_CR37","first-page":"559","volume":"20","author":"H Mahmoodzadeh","year":"2010","unstructured":"Mahmoodzadeh H, Movafegh A, Beigi NM. Preoperative oral dextromethorphan does not reduce pain or morphine consumption after open cholecystectomy. Middle East J Anaesthesiol. 2010;20:559\u201363.","journal-title":"Middle East J Anaesthesiol"},{"key":"7240_CR38","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1213\/01.ANE.0000100151.56901.EB","volume":"98","author":"AA Weinbroum","year":"2004","unstructured":"Weinbroum AA, Bender B, Nirkin A, Chazan S, Meller I, Kollender Y. Dextromethorphan-associated epidural patient-controlled analgesia provides better pain- and analgesics-sparing effects than dextromethorphan-associated intravenous patient-controlled analgesia after bone-malignancy resection&colon; a randomized, placebo-controlled, double-blinded study. Anesthesia Analgesia. 2004;98:714\u201322.","journal-title":"Anesthesia Analgesia"},{"key":"7240_CR39","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1002\/cncr.11330","volume":"97","author":"AA Weinbroum","year":"2003","unstructured":"Weinbroum AA, Bender B, Bickels J, Nirkin A, Marouani N, Chazam S, et al. Preoperative and postoperative dextromethorphan provides sustained reduction in postoperative pain and patient-controlled epidural analgesia requirement: a randomized, placebo-controlled, double-blind study in lower-body bone malignancy-operated patients. Cancer. 2003;97:2334\u201340.","journal-title":"Cancer"},{"key":"7240_CR40","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/cncr.10784","volume":"95","author":"AA Weinbroum","year":"2002","unstructured":"Weinbroum AA, Gorodetzky A, Nirkin A, Kollender Y, Bickels J, Marouani N, et al. Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study. Cancer. 2002;95:1164\u201370.","journal-title":"Cancer"},{"key":"7240_CR41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1213\/00000539-200103000-00035","volume":"92","author":"SAK Helmy","year":"2001","unstructured":"Helmy SAK, Bali A. The effect of the preemptive use of the NMDA receptor antagonist dextromethorphan on postoperative analgesic requirements. Anesthesia Analgesia. 2001;92:739\u201344.","journal-title":"Anesthesia Analgesia"},{"key":"7240_CR42","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1213\/00000539-199811000-00029","volume":"87","author":"RF Grace","year":"1998","unstructured":"Grace RF, Power I, Umedaly H, Zammit A, Mersiades M, Cousins MJ, et al. Preoperative dextromethorphan reduces intraoperative but not postoperative morphine requirements after laparotomy. Anesthesia Analgesia. 1998;87:1135.","journal-title":"Anesthesia Analgesia"},{"key":"7240_CR43","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1742-7843.2010.00559.x","volume":"107","author":"M Suski","year":"2010","unstructured":"Suski M, Bujak-Gizycka B, Madej J, Kacka K, Dobrogowski J, Woron J, et al. Co-administration of dextromethorphan and morphine: reduction of post-operative pain and lack of influence on morphine metabolism. Basic Clin Pharmacol. 2010;107:680\u20134.","journal-title":"Basic Clin Pharmacol"},{"key":"7240_CR44","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1526-4637.2006.00226.x","volume":"8","author":"W Chau-In","year":"2007","unstructured":"Chau-In W, Sukmuan B, Ngamsangsirisapt K, Jirarareungsak W. Efficacy of pre- and postoperative oral dextromethorphan for reduction of intra- and 24-hour postoperative morphine consumption for transabdominal hysterectomy. Pain Med. 2007;8:462\u20137.","journal-title":"Pain Med"},{"key":"7240_CR45","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/ana.410360619","volume":"36","author":"D Hollander","year":"1994","unstructured":"Hollander D, Pradas J, Kaplan R, McLeod HL, Evans WE, Munsat TL. High-dose dextromethorphan in amyotrophic lateral sclerosis: phase I safety and pharmacokinetic studies. Ann Neurol. 1994;36:920\u20134.","journal-title":"Ann Neurol"},{"key":"7240_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0009-9236(96)90056-9","volume":"60","author":"DA Capon","year":"1996","unstructured":"Capon DA, Bochner F, Kerry N, Mikus G, Danz C, Somogyi AA. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans*. Clin Pharmacol Ther. 1996;60:295\u2013307.","journal-title":"Clin Pharmacol Ther"},{"issue":"2\u20133","key":"7240_CR47","first-page":"94","volume":"93","author":"A Kazis","year":"1996","unstructured":"Kazis A, Kimiskidis V, Niopas I. Pharmacokinetics of dextromethorphan and dextrorphan in epileptic patients. Acta Neurol Scand. 1996;93(2\u20133):94\u20138.","journal-title":"Acta Neurol Scand"},{"key":"7240_CR48","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/PEC.0b013e31815a0667","volume":"23","author":"M Ganetsky","year":"2007","unstructured":"Ganetsky M, Babu KM, Boyer EW. Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy. Pediatr Emerg Care. 2007;23:829\u201331.","journal-title":"Pediatr Emerg Care"},{"key":"7240_CR49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/15563650701668625","volume":"46","author":"AR Schwartz","year":"2008","unstructured":"Schwartz AR, Pizon AF, Brooks DE. Dextromethorphan-induced serotonin syndrome. Clin Toxicol. 2008;46:771\u20133.","journal-title":"Clin Toxicol"},{"key":"7240_CR50","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/NRL.0b013e3180f60bd8","volume":"13","author":"LL Werling","year":"2007","unstructured":"Werling LL, Lauterbach EC, Calef U. Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action. Neurologist. 2007;13:272\u201393.","journal-title":"Neurologist"},{"key":"7240_CR51","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.mehy.2012.02.012","volume":"78","author":"EC Lauterbach","year":"2012","unstructured":"Lauterbach EC. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan. Med Hypotheses. 2012;78:693\u2013702.","journal-title":"Med Hypotheses"},{"key":"7240_CR52","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/ALN.0b013e3181e90914","volume":"113","author":"RW Loftus","year":"2010","unstructured":"Loftus RW, Yeager MP, Clark JA, Brown JR, Abdu WA, Sengupta DK, et al. Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. Anesthesiology. 2010;113:639\u201346.","journal-title":"Anesthesiology"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07240-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07240-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07240-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T22:05:20Z","timestamp":1702159520000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07240-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7240"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07240-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been submitted for ethics approval by the University of Southern California Health Science IRB on 20 March 2022. Once accepted, IRB approval information will be made available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}